Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.
about
Current perspectives on the immunopathogenesis of systemic sclerosisAnimal models of systemic sclerosis: their utility and limitations.Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts.Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.Novel therapy in the treatment of scleroderma.Endothelin-1 gene regulationConstitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblastsRetrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.Role of host genetics in fibrosis.Endothelin in the female vasculature: a role in aging?Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.Molecular mechanisms of atrial fibrosis: implications for the clinic.Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.New approaches in Sjögren's syndrome therapy.Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study.Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis.Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK.Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A.Effects of endothelins on hepatic stellate cell synthesis of endothelin-1 during hepatic wound healing.Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features.Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases.
P2860
Q26741264-097A72AF-D2BC-4EE6-B2EB-F601746C2E23Q28390528-C0C573D5-D643-4BD4-8B5B-2BF9490002D7Q31437221-EAD98BBD-3B0C-4F9D-BB4A-52DF2C4F7A43Q33840143-6FE6C097-9A52-4BF1-8496-A7DA40201E9AQ33851819-556761B2-6088-418D-BD82-98E60C38DE69Q34104580-A95E10D0-A5FD-4168-B480-C3FDEB8A2BB4Q34421747-678AE165-DA75-47D7-831C-A4F317A17542Q35070899-D9E35A32-496F-4890-B881-ED2CAA38B757Q35605567-87411E2A-9919-404F-AA0B-66B8688C327CQ37118158-BF98F6F6-BB32-4A50-B04A-5007751D6ECAQ37515708-3765F628-487F-4A4C-8D1C-DDB4C39C99CCQ37644559-F51E3F2B-C90B-4ED5-82C7-A57E78ED0A84Q37669591-D618BC2D-9729-4FEF-B602-6E362B9EEC72Q37689681-7D83C8F3-2AD9-4080-8329-83DC1707A386Q38749008-3ECBA5E8-BCBF-4313-B986-13578F4A8FD3Q38869606-2C28ED4C-6CF9-4AA0-9A37-F67D8A742520Q40238844-454A5340-29FA-442F-91FB-CD37C170BDBFQ40386689-0DFEA890-C329-41C0-BBD7-AFFDA030A976Q40785888-C1554D06-BA58-4488-8874-A74997A42600Q40902696-D68D09C6-002B-44D8-B512-8E416B52962EQ41815275-FAEA9167-F145-4590-AC0B-87960F148E90Q41972569-92B8E51F-E630-461D-9EC4-8AF92CD4FD19Q42416370-78B81576-514D-4ACA-9FE4-FCD0144A6304Q42459183-9D8E9AED-FE0B-4BA2-9382-B69C838F9177Q42492897-68C473B1-F00C-4475-B865-EF2548029789Q43994820-997FB0D9-F4DA-4CAC-8B7C-21B3621C02C9Q44665390-F73D4743-149B-42A7-B4BC-10FABCB6FD37Q47880572-7F2DC731-763B-46BB-A7C5-C74A10E363A9
P2860
Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Increased endothelin-1 product ...... ients with systemic sclerosis.
@ast
Increased endothelin-1 product ...... ients with systemic sclerosis.
@en
Increased endothelin-1 product ...... ients with systemic sclerosis.
@nl
type
label
Increased endothelin-1 product ...... ients with systemic sclerosis.
@ast
Increased endothelin-1 product ...... ients with systemic sclerosis.
@en
Increased endothelin-1 product ...... ients with systemic sclerosis.
@nl
prefLabel
Increased endothelin-1 product ...... ients with systemic sclerosis.
@ast
Increased endothelin-1 product ...... ients with systemic sclerosis.
@en
Increased endothelin-1 product ...... ients with systemic sclerosis.
@nl
P2093
P2860
P356
P1476
Increased endothelin-1 product ...... ients with systemic sclerosis.
@en
P2093
Ishizuka T
Kawaguchi Y
Nakamura H
P2860
P304
P356
10.1136/ARD.53.8.506
P407
P577
1994-08-01T00:00:00Z